{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:36:32Z","timestamp":1753875392606,"version":"3.41.2"},"reference-count":11,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"no funding"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2106749","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T23:19:51Z","timestamp":1659395991000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged \u226560 years"],"prefix":"10.1080","volume":"18","author":[{"given":"J. Kevin","family":"Yin","sequence":"first","affiliation":[{"name":"Global Medical Affairs, Sanofi, Singapore"},{"name":"Faculty of Medicine and Health, The University of Sydney, NSW, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Pepin","sequence":"additional","affiliation":[{"name":"Global Clinical Sciences, Sanofi, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robertus","family":"van Aalst","sequence":"additional","affiliation":[{"name":"Department of Modeling, Epidemiology and Data Science, Global Medical Affairs, Sanofi, Lyon, France"},{"name":"Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA"},{"name":"Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Loiacono","sequence":"additional","affiliation":[{"name":"Global Medical Evidence Generation, Sanofi, Swiftwater, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine I.","family":"Samson","sequence":"additional","affiliation":[{"name":"Global Medical Affairs, Sanofi, Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,8]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.004"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1983387"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2085470"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315727"},{"key":"e_1_3_2_6_1","unstructured":"The U.S. Centers for Disease Control and Prevention (CDC). Vaccine effectiveness: how well do flu vaccines work? 2021. https:\/\/www.cdc.gov\/flu\/vaccines-work\/vaccineeffect.htm."},{"key":"e_1_3_2_7_1","unstructured":"The U.S. Centers for Disease Control and Prevention (CDC). Seasonal Influenza Vaccine Effectiveness 2011-2012. 2018. https:\/\/www.cdc.gov\/flu\/vaccines-work\/2011-2012.html."},{"key":"e_1_3_2_8_1","unstructured":"The U.S. Centers for Disease Control and Prevention (CDC). Seasonal Influenza Vaccine Effectiveness 2012-2013. 2018. https:\/\/www.cdc.gov\/flu\/vaccines-work\/2012-2013.html."},{"key":"e_1_3_2_9_1","first-page":"185","article-title":"Vaccines against influenza: WHO position paper","volume":"19","author":"World Health Organization (WHO)","year":"2022","unstructured":"World Health Organization (WHO). Vaccines against influenza: WHO position paper. Wkly Epidemiol Rec 2022;19:185\u2013208.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.08.036"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02329-1"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00557-9"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2106749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:33:30Z","timestamp":1737048810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2106749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2106749"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2106749","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"type":"print","value":"2164-5515"},{"type":"electronic","value":"2164-554X"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2106749"}}